2025-04-11 - Analysis Report
## Honeywell International Inc. (HON) Stock Analysis

**0. Key Figures Overview:**

HON's cumulative return lags behind the S&P 500 (VOO) significantly.  Recent price action shows the stock trading below its 5, 20, and 60-day moving averages, indicating bearish momentum. Technical indicators (RSI and PPO) suggest the stock is oversold, but the negative expected return warrants caution.  Earnings show some fluctuation but generally remain strong.

**1. Performance Comparison:**

Honeywell International Inc. (HON) is a diversified technology and manufacturing company.

* **HON Cumulative Return:** 28.87%
* **VOO (S&P 500) Cumulative Return:** 62.31%
* **Return Difference:** -33.4%
* **Relative Divergence:** 16.3% (This indicates HON's underperformance relative to the S&P 500 is relatively lower than its historical minimum underperformance)

The table below shows the Compound Annual Growth Rate (CAGR), Maximum Drawdown (MDD), Alpha, Beta, and Market Capitalization for HON over various periods.  Noteworthy is the negative CAGR in the most recent periods, significantly underperforming the market.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 37.0% | 56.3% | 8.0% | 0.1 | 81.4 |
| 2016-2018  | 24.0% | 63.2% | 6.0% | 0.1 | 74.7 |
| 2017-2019  | 43.0% | 63.2% | 14.0% | 0.5 | 102.1 |
| 2018-2020  | 51.0% | 63.2% | 26.0% | 0.4 | 125.5 |
| 2019-2021  | 49.0% | 59.5% | -6.0% | 0.5 | 125.2 |
| 2020-2022  | 34.0% | 71.1% | 28.0% | 0.5 | 131.3 |
| 2021-2023  | -10.0% | 71.1% | -27.0% | 0.7 | 131.3 |
| 2022-2024  | -21.0% | 71.6% | -38.0% | 0.7 | 144.5 |
| 2023-2025  | -42.0% | 72.1% | -51.0% | 1.1 | 125.0 |


**2. Recent Price Action:**

* **Closing Price:** $194.35
* **Last Market Price:** $194.17
* **5-Day Moving Average:** $192.47
* **20-Day Moving Average:** $206.56
* **60-Day Moving Average:** $211.44

The price is below all three moving averages, suggesting a downward trend. The recent price drop of $2.48 (from $199.1 to $194.17) indicates a short-term bearish trend.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4271 (Medium Risk)
* **RSI:** 35.96 (Oversold territory; generally below 30 is considered oversold)
* **PPO:** -1.26 (Negative, indicating bearish momentum)
* **20-Day Relative Divergence Change:** -3.3 (Short-term downward trend)
* **Expected Return:** -5.8% (Negative expected return over the short term)
* **Long-Term Expected Return vs. S&P 500:**  The provided data doesn't directly give a long-term (2+ years) expected outperformance relative to the S&P 500, but the historical alpha values show mixed results, with some periods exceeding the S&P 500 and others lagging significantly.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-24 | 2.17 | $9.73B        |
| 2024-07-25 | 2.37 | $9.58B        |
| 2024-04-25 | 2.24 | $9.11B        |
| 2023-10-26 | 2.29 | $9.21B        |
| 2024-10-24 | 2.29 | $9.21B        | *(Duplicate entry, likely an error)*


Revenue is relatively stable, hovering around $9.5B - $9.7B. EPS shows some quarter-to-quarter fluctuation, but no clear strong trend is apparent from this limited data.  The duplication in the October 2024 entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue      | Profit Margin |
|---------|---------------|---------------|
| 2024-12-31 | $10.09B      | 36.38%       |
| 2024-09-30 | $9.73B       | 38.54%       |
| 2024-06-30 | $9.58B       | 38.85%       |
| 2024-03-31 | $9.11B       | 38.68%       |
| 2023-12-31 | $9.44B       | 34.31%       |

Revenue shows a generally upward trend. Profit margins are relatively high and stable, though there's a slight dip in Q4 2023.

**Capital and Profitability:**

| Quarter | Equity       | ROE           |
|---------|---------------|---------------|
| 2024-12-31 | $18.62B      | 6.90%        |
| 2024-09-30 | $17.41B      | 8.12%        |
| 2024-06-30 | $16.95B      | 9.11%        |
| 2024-03-31 | $16.45B      | 8.89%        |
| 2023-12-31 | $15.86B      | 7.97%        |

Equity is growing steadily, indicating a healthy financial position. ROE fluctuates but generally remains strong.


**6. Overall Analysis:**

HON is currently underperforming the S&P 500, showing negative returns in recent periods.  While technical indicators suggest oversold conditions, the negative expected return and below-average moving averages indicate caution.  Fundamentals, however, appear relatively strong, with stable revenues and high profit margins.  The short-term outlook is bearish, but the long-term prospects depend heavily on future market performance and HON's ability to overcome current headwinds.  Further investigation into the reasons for the recent underperformance is needed before making any investment decisions.  The duplicated earnings data should be verified and clarified.
